{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T13:08:48Z","timestamp":1754399328934,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:00:00Z","timestamp":1539993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1095-y","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:03:12Z","timestamp":1540026192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of transvenous cardiac implantable electronic devices in chronic hemodialysis patients: a single-center, observational comparative study"],"prefix":"10.1186","volume":"19","author":[{"given":"Seonjeong","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi Byoung","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai Won","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngjin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Won","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0639-451X","authenticated-orcid":false,"given":"Yong-Pil","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,20]]},"reference":[{"key":"1095_CR1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.hrthm.2008.04.013","volume":"5","author":"BL Wilkoff","year":"2008","unstructured":"Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, et al. Heart Rhythm Society; European heart rhythm association; American College of Cardiology; American Heart Association; European Society of Cardiology; heart failure association of ESC; Heart Failure Society of America. HRS\/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm. 2008;5:907\u201325.","journal-title":"Heart Rhythm"},{"key":"1095_CR2","doi-asserted-by":"crossref","unstructured":"Kusztal M, Nowak K. Cardiac implantable electronic device and vascular access: Strategies to overcome problems. J Vasc Access. 2018:1129729818762981 [Epub ahead of print].","DOI":"10.1177\/1129729818762981"},{"key":"1095_CR3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.hrthm.2008.04.015","volume":"5","author":"AE Epstein","year":"2008","unstructured":"Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. American College of Cardiology\/American Heart Association task force on practice; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm. 2008;5:934\u201355.","journal-title":"Heart Rhythm"},{"key":"1095_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/j.ajkd.2015.01.028","volume":"66","author":"RK Dhamija","year":"2015","unstructured":"Dhamija RK, Tan H, Philbin E, Mathew RO, Sidhu MS, Wang J, et al. Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections. Am J Kidney Dis. 2015;66:154\u20138.","journal-title":"Am J Kidney Dis"},{"key":"1095_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1525-139X.2012.01103.x","volume":"26","author":"TF Saad","year":"2013","unstructured":"Saad TF, Hentschel DM, Koplan B, Wasse H, Asif A, Patel DV, et al. ASDIN Clinical Practice Committee Workgroup. Cardiovascular implantable electronic device leads in CKD and ESRD patients: review and recommendations for practice. Semin Dial. 2013;26:114\u201323.","journal-title":"Semin Dial"},{"key":"1095_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4174\/astr.2016.90.4.224","volume":"90","author":"SM Kim","year":"2016","unstructured":"Kim SM, Han Y, Kwon H, Hong HS, Choi JY, Park H, et al. Impact of a preoperative evaluation on the outcomes of an arteriovenous fistula. Ann Surg Treat Res. 2016;90:224\u201330.","journal-title":"Ann Surg Treat Res"},{"key":"1095_CR7","doi-asserted-by":"publisher","first-page":"e0184168","DOI":"10.1371\/journal.pone.0184168","volume":"12","author":"Y Han","year":"2017","unstructured":"Han Y, Choo SJ, Kwon H, Lee JW, Chung CH, Kim H, et al. Effects of upper-extremity vascular access creation on cardiac events in patients undergoing coronary artery bypass grafting. PLoS One. 2017;12:e0184168.","journal-title":"PLoS One"},{"key":"1095_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/sdi.12249","volume":"28","author":"TF Saad","year":"2015","unstructured":"Saad TF, Ahmed W, Davis K, Jurkovitz C. Cardiovascular implantable electronic devices in hemodialysis patients: prevalence and implications for arteriovenous hemodialysis access interventions. Semin Dial. 2015;28:94\u2013100.","journal-title":"Semin Dial"},{"key":"1095_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10016-003-0048-4","volume":"17","author":"TH Teruya","year":"2003","unstructured":"Teruya TH, Abou-Zamzam AM, Limm W, Wong L, Wong L. Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers. Ann Vasc Surg. 2003;17:526\u20139.","journal-title":"Ann Vasc Surg"},{"key":"1095_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.avsg.2017.08.003","volume":"47","author":"SM Kim","year":"2018","unstructured":"Kim SM, Ko HK, Noh M, Ko GY, Kim MJ, Kwon TW, et al. Factors Affecting Patency following successful percutaneous intervention for dysfunctional hemodialysis vascular access. Ann Vasc Surg. 2018;47:54\u201361.","journal-title":"Ann Vasc Surg"},{"key":"1095_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260\u201372.","journal-title":"Lancet"},{"key":"1095_CR12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/sdi.12073","volume":"26","author":"CS Tan","year":"2013","unstructured":"Tan CS, Jie C, Joe J, Irani ZD, Ganguli S, Kalva SP, et al. The impact of transvenous cardiac devices on vascular access patency in hemodialysis patients. Semin Dial. 2013;26:728\u201332.","journal-title":"Semin Dial"},{"key":"1095_CR13","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1525-139X.2012.01053.x","volume":"25","author":"A Asif","year":"2012","unstructured":"Asif A, Salman L, Lopera G, Haqqie SS, Carrillo R. Transvenous cardiac implantable electronic devices and hemodialysis catheters: recommendations to curtail a potentially lethal combination. Semin Dial. 2012;25:582\u20136.","journal-title":"Semin Dial"},{"key":"1095_CR14","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.jacc.2005.02.037","volume":"45","author":"G Lin","year":"2005","unstructured":"Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM 3rd, Hayes DL. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol. 2005;45:1672\u20135.","journal-title":"J Am Coll Cardiol"},{"key":"1095_CR15","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1046\/j.1460-9592.2002.01301.x","volume":"25","author":"SS Da Costa","year":"2002","unstructured":"Da Costa SS, Scalabrini Neto A, Costa R, Caldas JG, Martinelli Filho M. Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study. Pacing Clin Electrophysiol. 2002;25:1301\u20136.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1095_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1525-139X.2009.00636.x","volume":"22","author":"A Asif","year":"2009","unstructured":"Asif A, Salman L, Carrillo RG, Garisto JD, Lopera G, Barakat U, et al. Patency rates for angioplasty in the treatment of pacemaker-induced central venous stenosis in hemodialysis patients: results of a multi-center study. Semin Dial. 2009;22:671\u20136.","journal-title":"Semin Dial"},{"key":"1095_CR17","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.jacc.2007.01.072","volume":"49","author":"MR Sohail","year":"2007","unstructured":"Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter defibrillator infections. J Am Coll Cardiol. 2007;49:1851\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1095_CR18","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1001\/archinternmed.2011.441","volume":"171","author":"MR Sohail","year":"2011","unstructured":"Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011;171:1821\u20138.","journal-title":"Arch Intern Med"},{"key":"1095_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000366453","volume":"40","author":"O Opelami","year":"2014","unstructured":"Opelami O, Sakhuja A, Liu X, Tang WH, Schold JD, Navaneethan SD. Outcomes of infected cardiovascular implantable devices in dialysis patients. Am J Nephrol. 2014;40:280\u20137.","journal-title":"Am J Nephrol"},{"key":"1095_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/europace\/euv053","volume":"17","author":"KA Polyzos","year":"2015","unstructured":"Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17:767\u201377.","journal-title":"Europace"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1095-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1095-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1095-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T19:17:28Z","timestamp":1571512648000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1095-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,20]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1095"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1095-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2018,10,20]]},"assertion":[{"value":"2 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research was approved by the Institutional Review Board of Asan Medical Center (2018\u20130442), which waived the need for informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"281"}}